President Trump announced plans to impose significant tariffs on pharmaceuticals, which had previously been exempt from new levies. He claims this move will encourage drug manufacturers to relocate production to the U.S. from countries like China. While the specifics of these tariffs remain unclear, industry leaders express concern over potential negative impacts on research funding and job stability. Trump’s reliance on emergency powers to enforce these tariffs has drawn criticism, with some viewing it as an overreach of authority. Additionally, he recently increased tariffs on China to 125%.

Source: https://www.supplychaindive.com/news/trump-major-tariffs-pharmaceuticals-coming-europe/744883/